New frontiers in oncolytic viruses: optimizing and selecting for virus strains with improved efficacy
Kenneth Lundstrom PanTherapeutics, Lutry, Switzerland Abstract: Oncolytic viruses have demonstrated selective replication and killing of tumor cells. Different types of oncolytic viruses – adenoviruses, alphaviruses, herpes simplex viruses, Newcastle disease viruses, rhabdoviruses, Coxsack...
Enregistré dans:
Auteur principal: | Lundstrom K |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2018
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/521c536d77ef43ef940735d343d5d01b |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Methodological Characteristics of Clinical Trials Supporting the Marketing Authorisation of Advanced Therapies in the European Union
par: Carolina Iglesias-Lopez, et autres
Publié: (2021) -
Oncolytic Viruses: Newest Frontier for Cancer Immunotherapy
par: Masmudur M. Rahman, et autres
Publié: (2021) -
Registration, publication, and outcome reporting among pivotal clinical trials that supported FDA approval of high-risk cardiovascular devices before and after FDAAA
par: Matthew J. Swanson, et autres
Publié: (2021) -
Viral vector-based vaccines against SARS-CoV-2
par: Kenneth Lundstrom
Publié: (2021) -
The Evolution and Future of Targeted Cancer Therapy: From Nanoparticles, Oncolytic Viruses, and Oncolytic Bacteria to the Treatment of Solid Tumors
par: Kyle M. Pierce, et autres
Publié: (2021)